Welcome to the Prostate Cancer Institute of Arizona
Multidisciplinary Prostate Cancer Treatment
The Prostate Cancer Institute of Arizona is Arizona's leading Prostate Cancer practice with experts in Urology, Radiation Oncology, and Medical Oncology. Every patient is evaluated in a multi-specialty environment to provide the patient with a comprehensive assessment, and integrated recommendation for management for their prostate cancer. Our team offers the leading treatment modalities including Varian Rapid Arc Image Guided Radiation Therapy, da Vinci Robotic Radical Prostatectomy, Prostate Cancer Chemotherapy/Immunotherapy, Hormonal Therapy.
Prostate cancer is the most common cancer in US men accounting for about a third of all cancers. The diagnosis is only the beginning of a journey in understanding the complexity of prostate cancer and the variety of treatments offered. Unlike other cancers which dictate a simple algorithm in the treatment process, there are several options to treat prostate cancer. Furthermore, those options are inherently unique among individual men dependent on their age, their lifestyle, their life expectancy, and their co-morbid medical problems. Our mission is to help you understand prostate cancer, so that you are empowered to make the correct, and unique choice, to optimize the best outcomes for you as the individual.
Our Physicians at the Prostate Cancer Institute of Arizona have been trained from the nation's leading tertiary training centers that include: Memorial Sloan-Kettering Cancer Center, Seattle Prostate Institute, Stanford University Medical Center, The Cleveland Clinic Medical Center, University of Washington Medical Center, Northwestern University Medical Center, The Ohio State University Medical Center, University of California San Francisco Medical Center. At the Prostate Cancer Institute or Arizona, we strive to offer a comprehensive collection of expertise, and experience, that you can draw upon to make your decision in choosing the optimal treatment. Some of our physicians are fellowship-trained in robotic surgery for prostate cancer and in urologic oncology focusing on prostate cancer. Our offices are located in Phoenix, Glendale, Peoria, Goodyear, Paradise Valley, and some of our physicians have served the Phoenix valley over 10 years. Prostate Cancer Institute of Arizona is accreditated by the Joint Commission.
Prostate Cancer Institute of Arizona
14155 N. 83rd Ave., Suite #127
Peoria, AZ 85381
or 1 (877) 476-0926
Surprise Radiation Center
14674 W. Mountain View Blvd., Suite 104
Surprise, AZ 85374
Prostate Cancer Institute of Arizona attains Joint Commission Gold Seal Accreditation
Prostate Cancer Institute of Arizona attains the Joint Commission Gold Seal Accreditation. In order to earn this zenith award, we underwent a rigorous unannounced on-site survey in July 2011. A team of Joint Commission expert surveyors evaluated the center for compliance with standards of care specific to the needs of patients, including infection prevention and control, leadership and medication management. We are proud of this enormous distinction-being the only center in Arizona with Joint Commision Accreditation, and being the second in the US. The news was released by the Peoria Times.
Recently Presented Study Questions Proton Therapy
A recent study presented at the American Society of Clinical Oncology (ASCO) brought new questions regarding a new and costly form of therapy for prostate cancer called Proton Therapy. The study is a retrospective review of medicare SEER records from 2000-2009 showing that patients can have up to a 33% more risk of GI side effects comparing to conventional radiation therapy without any difference in cancer control outcomes. This was widely covered in the media at ABC News and Fox News. Read the ASCO clinical abstract here.
October 13, 2011
US Preventative Services Task Force on PSA Testing
The US Preventative Services Task Force (USPSTF) issues a grade of D for using PSA in screeing for prostate cancer, sends "the wrong message" according to many experts in the field. Read the Medscape Article. Secondly, to abolish the PSA level for screening would resort to digital rectal exams prior to the PSA era. Look at SEER survival statistics from the National Cancer Institute Table 23.9. The PSA test was accepted as a screening tool around 1990, beginning the PSA era. The survival rates for prostate cancer patients has dramatically reached upwards of 99% in the last decade. The USPSTF weighs heavily on the harms of treatment, and relies on outdated data that does not reflect the dramatically changing technologies in treating prostate cancer. Prostate Cancer Institute of Arizona utilizes the latest in IMRT/IGRT with Varian Rapid Arc Therapy and the da Vinci Robot.
Prostate Cancer Institute opens new Radiation Center in Surprise
We are pleased to announce the addition of a radiation center in Surprise Arizona on 14674 W. Mountain View Blvd., Suite 104. The center will allow us to bring the latest cutting-edge Varian technology closer to our patients.